Cargando…

Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease

A novel infectious disease, coronavirus disease-2019 (COVID-19), spread globally since December 2019. Without effective treatment and vaccination, the strategies to restrain this disease are only keeping social distance, maintaining personal hygiene, quarantine, and isolation. However, thrice-a-week...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Szu-Yuan, Tang, Yu-Shuo, Chan, Yu-Jiun, Tarng, Der-Cherng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434020/ https://www.ncbi.nlm.nih.gov/pubmed/32433343 http://dx.doi.org/10.1097/JCMA.0000000000000356

Ejemplares similares

Artificial Intelligence for Risk Prediction of End-Stage Renal Disease in Sepsis Survivors with Chronic Kidney Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2022)

Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study
por: Chang, Yu-Kang, et al.
Publicado: (2015)

Prediction of the risk of developing end-stage renal diseases in newly diagnosed type 2 diabetes mellitus using artificial intelligence algorithms
por: Ou, Shuo-Ming, et al.
Publicado: (2023)

Stroke and Risks of Development and Progression of Kidney Diseases and End-Stage Renal Disease: A Nationwide Population-Based Cohort Study
por: Wu, Chia-Lin, et al.
Publicado: (2016)

Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study
por: Chen, Yu-Hsin, et al.
Publicado: (2016)

COVID-19 Pandemic Impact on Dialysis Access Procedures for End Stage Renal Disease Patients
por: Shetty, Karthik, et al.
Publicado: (2022)

Hemodialysis vascular access care during the COVID-19 pandemic
por: Yang, Chih-Yu, et al.
Publicado: (2020)

Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access
por: Wu, Chih-Cheng, et al.
Publicado: (2017)

Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade
por: Lin, Chih-Ching, et al.
Publicado: (2017)

Sepsis and the Risks of Long-Term Renal Adverse Outcomes in Patients With Chronic Kidney Disease
por: Ou, Shuo-Ming, et al.
Publicado: (2022)

Impact of physical activity on the association between lipid profiles and mortality among older people
por: Ou, Shuo-Ming, et al.
Publicado: (2017)

More Impact of Microalbuminuria on Retinopathy Than Moderately Reduced GFR Among Type 2 Diabetic Patients
por: Chen, Yu-Hsin, et al.
Publicado: (2012)

The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
por: Wang, Xiaoyan, et al.
Publicado: (2023)

Hyperuricemia Predicts an Early Decline in Renal Function among Older People: A Community-Based Cohort Study
por: Tseng, Wei-Cheng, et al.
Publicado: (2019)

Impacts of Heart Failure and Physical Performance on Long-Term Mortality in Old Patients With Chronic Kidney Disease
por: Weng, Shuo-Chun, et al.
Publicado: (2021)

Volume Overload and Adverse Outcomes in Chronic Kidney Disease: Clinical Observational and Animal Studies
por: Hung, Szu-Chun, et al.
Publicado: (2015)

Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2017)

Severe Hypoglycemia as a Predictor of End-Stage Renal Disease in Type 2 Diabetes: A National Cohort Study
por: Lee, Yu-Li, et al.
Publicado: (2019)

Risk of COVID-19 and Cost Burden in End-Stage Renal Disease Patients and Policy Implications for Managing Nephrology Services during the COVID-19 Pandemic
por: Behlul, Seda, et al.
Publicado: (2022)

The Influence of Diabetes Mellitus on the Risks of End-Stage Kidney Disease and Mortality After Liver Transplantation
por: Lee, Chung-Ying, et al.
Publicado: (2022)

Trichostatin A Alleviates Renal Interstitial Fibrosis Through Modulation of the M2 Macrophage Subpopulation
por: Tseng, Wei-Cheng, et al.
Publicado: (2020)

Risk of end-stage renal disease associated with gout: a nationwide population study
por: Yu, Kuang-Hui, et al.
Publicado: (2012)

Renal Tubular TRPA1 as a Risk Factor for Recovery of Renal Function from Acute Tubular Necrosis
por: Wu, Chung-Kuan, et al.
Publicado: (2019)

Impact of dialysis modality on technique survival in end-stage renal disease patients
por: Lee, Jong-Hak, et al.
Publicado: (2016)

The Impact of Diabetes Mellitus on Vascular Biomarkers in Patients with End-Stage Renal Disease
por: Moon, Jeonggeun, et al.
Publicado: (2017)

FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy
por: Li, Szu-Yuan, et al.
Publicado: (2019)

Author Correction: FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy
por: Li, Szu-Yuan, et al.
Publicado: (2019)

Renal Tubular Epithelial TRPA1 Acts as An Oxidative Stress Sensor to Mediate Ischemia-Reperfusion-Induced Kidney Injury through MAPKs/NF-κB Signaling
por: Wu, Chung-Kuan, et al.
Publicado: (2021)

Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis
por: Kuo, Ko-Lin, et al.
Publicado: (2015)

Trajectory of Estimated Glomerular Filtration Rate and Malnourishment Predict Mortality and Kidney Failure in Older Adults With Chronic Kidney Disease
por: Weng, Shuo-Chun, et al.
Publicado: (2021)

Association of estimated glomerular filtration rate with all‐cause and cardiovascular mortality: the role of malnutrition–inflammation–cachexia syndrome
por: Ou, Shuo‐Ming, et al.
Publicado: (2016)

Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease
por: Li, Szu-yuan, et al.
Publicado: (2012)

Impact of the Changes in the End Stage Renal Disease Composite Rate
Publicado: (1989)

Estimated Glomerular Filtration Rate Decline Is a Better Risk Factor for Outcomes of Systemic Disease-Related Nephropathy than for Outcomes of Primary Renal Diseases
por: Weng, Shuo-Chun, et al.
Publicado: (2014)

Aldosterone and Mortality in Hemodialysis Patients: Role of Volume Overload
por: Hung, Szu-Chun, et al.
Publicado: (2013)

Physical frailty and long-term mortality in older people with chronic heart failure with preserved and reduced ejection fraction: a retrospective longitudinal study
por: Weng, Shuo-Chun, et al.
Publicado: (2021)

Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis Patients
por: Chou, Yi-Hsin, et al.
Publicado: (2022)

Predictors and Assessment of Hospice Use for End-Stage Renal Disease Patients in Taiwan
por: Chen, Hung-Cheng, et al.
Publicado: (2021)

The impact of dialysis therapy on older patients with advanced chronic kidney disease: a nationwide population-based study
por: Shih, Chia-Jen, et al.
Publicado: (2014)

Anxiety and depression in patients with end-stage renal disease: impact and management challenges – a narrative review
por: Goh, Zhong Sheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ccrhmq8vt35iab7ije572p9lif